AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
Orexin-A, an hypothalamic peptide with analgesic properties
Authors: Bingham, S Davey, PT Babbs, AJ Irving, EA Sammons, MJ Wyles, M Jeffrey, P Cutler, L Riba, I Johns, A Porter, RA Upton, N Hunter, AJ Parsons, AA
Citation: S. Bingham et al., Orexin-A, an hypothalamic peptide with analgesic properties, PAIN, 92(1-2), 2001, pp. 81-90
Stroke genomics: Approaches to identify, validate, and understand ischemicstroke gene expression
Authors: Read, SJ Parsons, AA Harrison, DC Philpott, K Kabnick, K O'Brien, S Clark, S Brawner, M Bates, S Gloger, I Legos, JJ Barone, FC
Citation: Sj. Read et al., Stroke genomics: Approaches to identify, validate, and understand ischemicstroke gene expression, J CEREBR B, 21(7), 2001, pp. 755-778
p38 Activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis
Authors: McLaughlin, B Pal, S Tran, MP Parsons, AA Barone, FC Erhardt, JA Aizenman, E
Citation: B. Mclaughlin et al., p38 Activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis, J NEUROSC, 21(10), 2001, pp. 3303-3311
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia
Authors: Barone, FC Irving, EA Ray, AM Lee, JC Kassis, S Kumar, S Badger, AM Legos, JJ Erhardt, JA Ohlstein, EH Hunter, AJ Harrison, DC Philpott, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145
Selective increases in cytokine expression in the rat brain in response tostriatal injection of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionateand interleukin-1
Authors: Allan, SM Harrison, DC Read, S Collins, B Parsons, AA Philpott, K Rothwell, NJ
Citation: Sm. Allan et al., Selective increases in cytokine expression in the rat brain in response tostriatal injection of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionateand interleukin-1, MOL BRAIN R, 93(2), 2001, pp. 180-189
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation
Authors: Bates, S Read, SJ Harrison, DC Topp, S Morrow, R Gale, D Murdock, P Barone, FC Parsons, AA Gloger, IS
Citation: S. Bates et al., Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation, MOL BRAIN R, 93(1), 2001, pp. 70-80
Determination of changes in mRNA expression in a rat model of neuropathic pain by Taqman (TM) quantitative RT-PCR
Authors: Macdonald, R Bingham, S Bond, BC Parsons, AA Philpott, KL
Citation: R. Macdonald et al., Determination of changes in mRNA expression in a rat model of neuropathic pain by Taqman (TM) quantitative RT-PCR, MOL BRAIN R, 90(1), 2001, pp. 48-56
Caspase mRNA expression in a rat model of focal cerebral ischemia
Authors: Harrison, DC Davis, RP Bond, BC Campbell, CA James, MF Parsons, AA Philpott, KL
Citation: Dc. Harrison et al., Caspase mRNA expression in a rat model of focal cerebral ischemia, MOL BRAIN R, 89(1-2), 2001, pp. 133-146
Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban
Authors: Erhardt, JA Ohlstein, EH Toomey, JR Gabriel, MA Willette, RN Yue, TL Barone, FC Parsons, AA
Citation: Ja. Erhardt et al., Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban, THROMB RES, 103(2), 2001, pp. 143-148
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
Authors: Barone, FC Irving, EA May, AM Lee, JC Kassis, S Kumar, S Badger, AM White, RF McVey, MJ Legos, JJ Erhardt, JA Nelson, AH Ohlstein, EH Hunter, AJ Ward, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321
Investigation of feline brain anatomy for the detection of cortical spreading depression with magnetic resonance imaging
Authors: Smith, JM James, MF Bockhorst, KHJ Smith, MI Bradley, DP Papadakis, NG Carpenter, TA Parsons, AA Leslie, RA Hall, LD Huang, CLH
Citation: Jm. Smith et al., Investigation of feline brain anatomy for the detection of cortical spreading depression with magnetic resonance imaging, J ANAT, 198, 2001, pp. 537-554
Inhibition of inflammation-induced thermal hypersensitivity by sumatriptanthrough activation of 5-HT1B/1D receptors
Authors: Bingham, S Davey, PT Sammons, M Raval, P Overend, P Parsons, AA
Citation: S. Bingham et al., Inhibition of inflammation-induced thermal hypersensitivity by sumatriptanthrough activation of 5-HT1B/1D receptors, EXP NEUROL, 167(1), 2001, pp. 65-73
Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes
Authors: Parsons, AA Bingham, S Raval, P Read, S Thompson, M Upton, N
Citation: Aa. Parsons et al., Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes, BR J PHARM, 132(7), 2001, pp. 1549-1557
Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs
Authors: Carel, I Ghaleh, B Edouard, A Dubois-Rande, JL Parsons, AA Giudicelli, JF Berdeaux, A
Citation: I. Carel et al., Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs, BR J PHARM, 132(5), 2001, pp. 1071-1083
Further characterisation of a thromboembolic model of stroke in the rat
Authors: Beech, JS Williams, SCR Campbell, CA Bath, PMW Parsons, AA Hunter, AJ Menon, DK
Citation: Js. Beech et al., Further characterisation of a thromboembolic model of stroke in the rat, BRAIN RES, 895(1-2), 2001, pp. 18-24
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia
Authors: Legos, JJ Erhardt, JA White, RF Lenhard, SC Chandra, S Parsons, AA Tuma, RF Barone, FC
Citation: Jj. Legos et al., SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia, BRAIN RES, 892(1), 2001, pp. 70-77
Cortical spreading depression produces increased cGMP levels in cortex andbrain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan
Authors: Read, SJ Hirst, WD Upton, N Parsons, AA
Citation: Sj. Read et al., Cortical spreading depression produces increased cGMP levels in cortex andbrain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan, BRAIN RES, 891(1-2), 2001, pp. 69-77
Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat
Authors: Irving, EA Bentley, DL Parsons, AA
Citation: Ea. Irving et al., Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat, ACT NEUROP, 102(6), 2001, pp. 627-635
Therapeutic potential of anti-inflammatory drugs in focal stroke
Authors: Barone, FC Parsons, AA
Citation: Fc. Barone et Aa. Parsons, Therapeutic potential of anti-inflammatory drugs in focal stroke, EXPERT OP I, 9(10), 2000, pp. 2281-2306
A quantitative analysis of cortical spreading depression events in the feline brain characterized with diffusion-weighted MRI
Authors: Bockhorst, KHJ Smith, JM Smith, MI Bradley, DP Houston, GC Carpenter, TA Hall, LD Papadakis, NG Parsons, AA Huang, CLH James, MF
Citation: Khj. Bockhorst et al., A quantitative analysis of cortical spreading depression events in the feline brain characterized with diffusion-weighted MRI, J MAGN R I, 12(5), 2000, pp. 722-733
The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan
Authors: MaassenVanDenBrink, A van den Broek, RWM de Vries, R Upton, N Parsons, AA Saxena, PR
Citation: A. Maassenvandenbrink et al., The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan, CEPHALALGIA, 20(6), 2000, pp. 538-545
Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453
Authors: Smith, MI Read, SJ Chan, WN Thompson, M Hunter, AJ Upton, N Parsons, AA
Citation: Mi. Smith et al., Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453, CEPHALALGIA, 20(6), 2000, pp. 546-553
SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat
Authors: Read, SJ Smith, MI Hunter, AJ Upton, N Parsons, AA
Citation: Sj. Read et al., SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat, CEPHALALGIA, 20(2), 2000, pp. 92-99
Identification of differentially expressed genes in dorsal root ganglia following partial sciatic nerve injury
Authors: Newton, RA Bingham, S Davey, PD Medhurst, AD Piercy, V Raval, P Parsons, AA Sanger, GJ Case, CP Lawson, SN
Citation: Ra. Newton et al., Identification of differentially expressed genes in dorsal root ganglia following partial sciatic nerve injury, NEUROSCIENC, 95(4), 2000, pp. 1111-1120
Decreased nuclear factor-kappa B DNA binding activity following permanent focal cerebral ischaemia in the rat
Authors: Irving, EA Hadingham, SJ Roberts, J Gibbons, M Chabot-Fletcher, M Roshak, A Parsons, AA
Citation: Ea. Irving et al., Decreased nuclear factor-kappa B DNA binding activity following permanent focal cerebral ischaemia in the rat, NEUROSCI L, 288(1), 2000, pp. 45-48
Risultati: 1-25 | 26-42